KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Interest Expenses (2017 - 2025)

Guardant Health's Interest Expenses history spans 9 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 82.95% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $3.9 million, up 50.99%, while the annual FY2025 figure was $3.9 million, 50.99% up from the prior year.
  • Interest Expenses for Q4 2025 was $1.2 million at Guardant Health, up from $943000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.2 million in Q4 2025 and bottomed at $643000.0 in Q4 2021.
  • The 5-year median for Interest Expenses is $645000.0 (2022), against an average of $710500.0.
  • The largest YoY upside for Interest Expenses was 7950.0% in 2021 against a maximum downside of 86.42% in 2021.
  • A 5-year view of Interest Expenses shows it stood at $643000.0 in 2021, then rose by 0.16% to $644000.0 in 2022, then grew by 0.16% to $645000.0 in 2023, then changed by 0.0% to $645000.0 in 2024, then skyrocketed by 82.95% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Interest Expenses are $1.2 million (Q4 2025), $943000.0 (Q3 2025), and $983000.0 (Q2 2025).